Introduction
Fibrin-fibrinogen degradation products (F.D.P.) have been found in the urine of most patients with glomerulonephritis (Naish et al., 1970; Clarkson et al., 1971; Briggs et al., 1972) . In such cases serum F.D.P. levels may be raised above normal (Briggs et al., 1972) but are often within the normal range (Humair et al., 1969; Preston et al., 1971) , and no correlation has been found between serum and urinary F.D.P. levels (Stiehm et al., 1971; Briggs et al., 1972) .
The urinary F.D.P. level has been found to correlate with proteinuria by some workers (Briggs et al., 1972; Shah et al., 1972) but not by others (Naish et al., 1970) . Clarkson et al. (1971) observed a correlation between urinary F.D.P. levels and proteinuria in patients with minimal-change and membranous glomerulonephritis but not in those with proliferative glomerulonephritis, while Naish et al. (1974) correlated urinary F.D.P. and proteinuria when the patients were grouped (by means of immunofluorescent techniques) according to the extent and localization of the intraglomerular fibrin deposits. Naish et al. (1970) and Clarkson et al. (1971) found no correlation between urinary F.D.P. excretion and the selectivity of the proteinuria whereas Ekert et al. (1972) found a significant linear correlation such that patients with the least selective proteinuria had the highest levels of urinary F.D.P. Briggs et al. (1972) reported that the range of urinary F.D.P. excretion in patients with renal disease was too great to be of diagnostic use, but Clarkson et al. (1971) found that the urinary F.D.P. level of patients with minimal-change, membranous, and inactive proliferative glomerulonephritis was less than 2 mg/l (2 ,ug/ml) whereas that of patients with active proliferative glomerulonephritis was more than 2 mg/l. Furthermore, in cases of active proliferative glomerulonephritis urinary F.D.P. excretion was closely related to the amount of intraglomerular fibrin as determined by electron microscopy.
A correlation between the urinary F.D.P. level and the blood urea was recorded by some workers (Stiehm et al., 1971) but not by others (Naish et al., 1970; Briggs et al., 1972) . Similarly conflicting reports exist as to the nature of the urinary degradation products. Nilsson (1971) found fibrinogen and the high molecular weight fragments FgX and FgY in the urine of patients with chronic nephritis, while Clarkson et al. (1971) found the low molecular weight fragments FgD and FgE in cases of proliferative glomerulonephritis and small amounts of all fragments in cases of minimal and membranous glomerulonephritis.
These many conflicting reports may in part be due to differences in the selection of cases for study and differences in the techniques used. Nevertheless, much controversy exists as to the nature, site of origin, and mechanism of clearance of urinary F.D.P. in renal disease. The present investigation was undertaken to clarify these points by studying patients with renal glomerular lesions causing proteinuria above 2 g/l (200 mg/100 ml). BRITISH MEDICAL JOURNAL 22 FEBRUARY 1975 contain detectable levels of F.D.P. In the 90 patients with the nephrotic syndrome a close correlation (r=0-7; P <0-001) was observed between the urinary F.D.P. excretion and the differential protein clearance whether measured as the U:S ratio of IgG:transferrin ( fig. 1) In 26 cases urine was concentrated tenfold to a hundredfold by pressure ultrafiltration in an Amicon chamber using an Amicon PM 10 membrane which is permeable only to molecules with molecular weights of less than 10 000. The 26 specimens were analysed by Sephadex G200 column chromatography. The analyses were carried out in 0-9% saline and alternate fractions were analysed for degradation products by tanned red cell haemagglutination inhibition immunoassay. The columns (100 x 2-5 cm) were characterized by means of a standard solution of blue dextran, IgG, albumin, and tryptophan using an SP 500 spectrophotometer and a Gilford 2000 multiple-sample absorbance recorder. Multiple control analyses were carried out using 1-ml volumes of solutions of (a) fibrinogen (Kabi grade L), (b) FgD and E, and (c) equal quantities of fibrinogen and FgD and E. All the solutions were made u,p in 0-9% saline to a final concentration of 1000 mg/l. In addition f-ml volumes of these solutions were added to 1 ml of urine from a normal subject (without proteinuria) which had been concentrated one hundredfold and to 1 ml of urine from a patient with minimal-change glomerulonephritis in relapse which had been concentrated one hundredfold (F.D.P. of concentrate= 10 mg/l). These analyses were carried out both to check the characterization of the columns and to confirm their ability to separate the various F.D.P. fragments in urine with heavy proteinuria which had been concentrated many times.
Results
The unconcentrated urine from 136 normal subjects did not Conversion: SI to Traditional Units-Urinary F.D.P.: lmg/l= 1 ,tg/ml. fibrinogen (M.W. 300 000) appear in the urine, and with nonselective proteinuria (IgG:Tf >04) fibrinogen becomes the predominant urinary F.D.P. Though plasma fibrinogen levels are above 3 g/l whereas the other products are present only in milligram quantities its large molecular size permits only small amounts to pass through the glomerular basement membrane. In cases of non-selective proteinuria, however, considerably more fibrinogen than any other product was present in the urine. The hypothesis that urinary F.D.P. originate in a process of differential filtration through a damaged glomerular basement membrane is supported by the work of Rayner et al. (1969) , who infused purified F.D.P. fragments into normal animals and observed that only fragments D and E were excreted in the urine and of Bouma et al. (1971) , who observed that the urine of patients undergoing thrombolytic therapy with streptokinase contained only fragments D and E. The high molecular weight fragments X and Y, however, have been found in the urine of patients with chronic glomerulonephritis (Hedner et al., 1974) , with acute renal failure, and after kidney transplantation (Bouma et al., 1971) , which are conditions characteristically associated with non-selective proteinuria. Furthermore, Wardle (1972/a, b) observed a good correlation between the urinary excretion of fibrinogen, determined by a chemical technique, and the urinary F.D.P. excretion and suggested that the presence of the high molecular weight fragments X and Y was associated with an impaired protein selectivity. The relation between urinary F.D.P. excretion and the selectivity of the proteinuria reported in this paper ( fig. 1 ) corresponds very closely with that observed by Ekert et al. (1972) in a study of 24 children with the nephrotic syndrome.
The contribution to the urinary F.D.P. level made by the renal tubules either by reabsorption or secretion of F.D.P. seems to be small because the urinary F.D.P. excretion of patients with primary renal tubular disorders-for example, renal tubular acidosis and cadmium nephropathy-has not exceeded 1-25 mg/l (Hall et al., 1974) and the tubules have only a very limited capacity to reabsorb molecules in the molecularweight range 50 000-300 000 (Blainey, 1967) .
In our series the 16 patients with minimal-change lesions all had a highly selective proteinuria and excreted only very small amounts of F.D.P. in the urine whereas there was a wide range of differential protein clearances in the other histological groups and a correspondingly wide range of urinary F.D.P. levels. Thus when the F.D.P. level in the unconcentrated urine of a patient with the nephrotic syndrome is less than 1 mg/l the proteinuria will be of a highly selective type and the glomerular lesion is most likely to be of the minimal-change type. A urinary F.D.P. level greater than 1 mg/l does not provide a reliable guide to the histological diagnosis, but it does enable an estimate of the differential protein clearance to be made.
We disagree with others (Clarkson et al., 1971; Briggs et al., 1972; Naish et al., 1974) in finding no correlation between the urinary F.D.P. excretion and the urinary protein excretion even when the patients were grouped according to the selectivity of the proteinuria or the type of renal disease. This discrepancy may be explained by the fact that all our patients had proteinuria above 3 g/day whereas in other series 40-50% of the patients had proteinuria of less than 3 g/day. The patients with low proteinuria had low or zero levels of F.D.P. in the urine which heavily weighted the correlation between urinary F.D.P. and proteinuria at its lower end. Clarkson et al. (1971) found a close correlation between the urinary F.D.P. concentration and the extent of intraglomerular fibrin deposition (as determined by electron microscopy) in proliferative glomerulonephritis. They suggested that the degradation products were derived from the local breakdown of intraglomerular fibrin deposits. These findings may be explained also, however, by the differential filtration of fibrinogen and F.D.P. from the plasma through the damaged glomerular basement membrane. Proliferative glomerulonephritis without extensive intraglomerular fibrin deposits is often of an endothelial, mesangial, or focal type associated with a selective or moderately selective proteinuria. In such cases mainly products of small molecular weight are filtered so only small quantities of F.D.P. are present in the urine. The development of extensive intraglomerular fibrin deposits in proliferative glomerulonephritis, however, is associated with severe and progressive renal impairment and a non-selective proteinuria. Gross disorganization of the basement membrane which permits filtration of fibrinogen and high molecular weight F.D.P. results in high urinary F.D.P. levels. Thus the location, extent, and distribution of intraglomerular fibrin deposits correlate with the severity ofthe glomerular basement membrane damage, which in turn determines the type and quantity of F.D.P. and fibrinogen filtered and excreted into the urine. This association between severe glomerular basement membrane damage and non-selective proteinuria leads also to the significant positive correlation between the urinary F.D.P. level and the serum creatinine and serum urea that we observed.
Thus the urinary F.D.P. constitutes a family of molecules with a range of molecular weights from 50 000 to 300 000 which have a common immunological identity by which they can be detected quantitatively. As the pore size of the glomerular basement membrane increases so successively larger fragments are filtered from the plasma and excreted in the urine, each contributing an increment to the urinary F.D.P. level. As fibrinogen is present in the plasma in the greatest amounts, when the pores in the basement membrane are large enough to permit the filtration of fibrinogen it becomes the predominant urinary F.D.P. In this way the urinary F.D.P. level has a close correlation with the differential protein clearance in cases of renal glomerular damage sufficient to cause proteinuria greater than 2 g/l.
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